CLINICAL TRIALS PROFILE FOR PERAMPANEL
✉ Email this page to a colleague
All Clinical Trials for PERAMPANEL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00368472 ↗ | 4-Year Open-Label Extension Phase of the Parallel-Group Study of E2007 in Patients With Refractory Partial Seizures | Completed | Eisai Inc. | Phase 2 | 2006-10-01 | The purpose of this study is to determine the safety of perampanel given as adjunctive, long-term treatment in patients with refractory partial onset seizures. |
NCT00505284 ↗ | An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy | Completed | Eisai Limited | Phase 2/Phase 3 | 2007-06-01 | The purpose of this study is to determine the efficacy and safety of Perampanel in patients with painful diabetic neuropathy. |
NCT00505284 ↗ | An Evaluation of the Efficacy and Safety of E2007 in Patients With Painful Diabetic Neuropathy | Completed | Eisai Inc. | Phase 2/Phase 3 | 2007-06-01 | The purpose of this study is to determine the efficacy and safety of Perampanel in patients with painful diabetic neuropathy. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PERAMPANEL
Condition Name
Clinical Trial Locations for PERAMPANEL
Trials by Country
Clinical Trial Progress for PERAMPANEL
Clinical Trial Phase
Clinical Trial Sponsors for PERAMPANEL
Sponsor Name